Pregabalin Terminated Phase 2 Trials for Pain / Breast Cancer / Malignant Lymphomas Prevention

IndicationsStatusPurposePhase
TerminatedPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT03407430Trial of Pregabalin for Granulocyte Colony-stimulating Factor (GCSF)-Induced Bone Pain